TY - CHAP
T1 - CABG versus PCI in multilesional vessel disease
AU - Wang, Yi Chih
AU - Hwang, Juey Jen
AU - Lin, Jiunn Lee
N1 - Publisher Copyright:
© Springer International Publishing Switzerland 2016.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - With numerous trials conducted during the 1970s and 1980s evaluating coronary artery bypass surgery (CABG) versus medical treatment for patients with coronary artery disease (CAD), the absolute benefi t of surgery was shown to be prominent especially for those with more extensive coronary involvement. However, the pronounced effect of CABG for patients with multivessel CAD (MVD) has faced continuing challenges since the introduction of percutaneous coronary intervention (PCI) and evolving revascularization technology, such as coronary stents.
AB - With numerous trials conducted during the 1970s and 1980s evaluating coronary artery bypass surgery (CABG) versus medical treatment for patients with coronary artery disease (CAD), the absolute benefi t of surgery was shown to be prominent especially for those with more extensive coronary involvement. However, the pronounced effect of CABG for patients with multivessel CAD (MVD) has faced continuing challenges since the introduction of percutaneous coronary intervention (PCI) and evolving revascularization technology, such as coronary stents.
KW - Bare metal stent (BMS)
KW - Coronary artery bypass surgery (CABG)
KW - Coronary artery disease (CAD)
KW - Drugeluting stent (DES)
KW - Multivessel disease (MVD)
KW - Percutaneous coronary intervention (PCI)
KW - Percutaneous transluminal coronary angioplasty (PTCA)
KW - Revascularization
UR - http://www.scopus.com/inward/record.url?scp=84978254085&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978254085&partnerID=8YFLogxK
U2 - 10.1007/978-3-319-26515-5_15
DO - 10.1007/978-3-319-26515-5_15
M3 - Chapter
AN - SCOPUS:84978254085
SN - 9783319265131
SP - 161
EP - 165
BT - Coronary Graft Failure
PB - Springer International Publishing
ER -